Clinical trial
Randomised Trial of Adjuvant Hepatic Intra-Arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma
NCT00027768 is registered in ClinicalTrials.gov with National Medical Research Council (NMRC), Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Trial of Adjuvant Hepatic Intra-Arterial Iodine-131-Lipiodol Following Curative Resection of Hepatocellular Carcinoma
- Lead sponsor
- National Medical Research Council (NMRC), Singapore
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2001
- Completion date
- Not reported
- Enrollment
- 300 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer